Post by LenioBio

Excited to announce that LenioBio has entered into a collaboration with Twist Bioscience, bringing together Twist's DNA manufacturing and automation capabilities with our ALiCE® cell-free protein expression platform. The goal: close the gap between computational protein design and real-world biology. AI can design new drug molecules, but models only improve when they're fed high-quality, rapidly generated experimental data. This collaboration is built to make that feedback loop as fast as possible. With ALiCE® delivering full-length, folded, functional proteins within 24 hours, teams working in AI-driven antibody and biologic discovery can access faster, higher-throughput lab-in-the-loop cycles — without the expression bottlenecks that slow model iteration. Full details in the press release attached. 📩 If your organisation is working on AI-enabled drug discovery and wants to learn more about what we can offer, we'd love to hear from you. Get in touch.